Elite Pharmaceuticals Inc ELTP:OTCQB

*Data is delayed | Exchange | USD
Last | 05/15/24 EDT
0.1399quote price arrow up+0.0004 (+0.2867%)
Volume
1,046,562
52 week range
0.03 - 0.21
Loading...
  • Open0.138
  • Day High0.149
  • Day Low0.1302
  • Prev Close0.1395
  • 52 Week High0.21
  • 52 Week High Date01/23/24
  • 52 Week Low0.03
  • 52 Week Low Date06/12/23

Key Stats

  • Market Cap142.388M
  • Shares Out1.02B
  • 10 Day Average Volume602,618.9
  • Dividend-
  • Dividend Yield-
  • Beta-0.15
  • YTD % Change-0.07

KEY STATS

  • Open0.138
  • Day High0.149
  • Day Low0.1302
  • Prev Close0.1395
  • 52 Week High0.21
  • 52 Week High Date01/23/24
  • 52 Week Low0.03
  • 52 Week Low Date06/12/23
  • Market Cap142.388M
  • Shares Out1.02B
  • 10 Day Average Volume602,618.9
  • Dividend-
  • Dividend Yield-
  • Beta-0.15
  • YTD % Change-0.07

RATIOS/PROFITABILITY

  • EPS (TTM)0.02
  • P/E (TTM)9.17
  • Fwd P/E (NTM)-
  • EBITDA (TTM)8.32M
  • ROE (TTM)40.62%
  • Revenue (TTM)47.318M
  • Gross Margin (TTM)45.82%
  • Net Margin (TTM)32.87%
  • Debt To Equity (MRQ)16.94%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Elite Pharmaceuticals Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and distributes niche generic products. The Company specializes in developing and manufacturing oral, controlled-release drug products. It owns multiple generic products which has been licensed to Prasco, LLC and TAGI Pharma. The Company’s segments include Abbreviated New Drug Applications (ANDA) and New Drug Application (NDA). The Company’s products include Phentermine HCl 37.5mg tablets...
Nasrat Hakim
Chairman of the Board, President, Chief Executive Officer
Carter Ward CPA
Chief Financial Officer, Treasurer, Company Secretary
Douglas Plassche
Executive Vice President - Operations
Address
165 Ludlow Ave
Northvale, NJ
07647-2305
United States

Top Peers

SYMBOLLASTCHG%CHG
RLMD
Relmada Therapeutics Inc
3.48UNCHUNCH
SCPH
scPharmaceuticals Inc
4.57UNCHUNCH
MDWD
Mediwound Ltd
17.84UNCHUNCH
OMER
Omeros Corp
4.17UNCHUNCH
CYTH
Cyclo Therapeutics Inc
1.43UNCHUNCH